THROMBOTIC THROMBOCYTOPENIC PURPURA
Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA trials appear
Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood disorder: drug cuts recurrence risk in japanese patients
Disease control CompletedThis study tested a drug called caplacizumab in 21 Japanese adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare condition causing dangerous blood clots. The goal was to see if the drug could prevent the disease from coming back. Participants received caplacizu…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA
Phase: PHASE2, PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
New drug combo may replace plasma exchange for rare blood disorder
Disease control CompletedThis study tested a new approach for people with a rare, life-threatening blood clotting disorder called immune-mediated thrombotic thrombocytopenic purpura (iTTP). Instead of the standard treatment of plasma exchange, participants received a combination of the drug caplacizumab …
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 04:38 UTC